Psyence BioMed names John Thorne project lead at new Texas ibogaine unit TIRC
PBM•Leadership appointments
CEO Jody Aufrichtig will also serve as CEO of the new Texas entity.
Dr. John Thorne was appointed project lead for the Texas ibogaine initiative.
Texas ibogaine unit formed
Psyence Biomedical formed Texas Ibogaine Research Corporation as a dedicated U.S. vehicle for its ibogaine development program.
